Apogee Therapeutics (APGE) Shares Issued (2022 - 2026)

Apogee Therapeutics (APGE) has 5 years of Shares Issued data on file, last reported at $2.2 million in Q1 2026.

• On a quarterly basis, Shares Issued rose 124.96% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 124.96% increase from a year earlier, with the FY2025 full-year figure at $5.6 million, up 8.83% from the prior year.
• Shares Issued for Q1 2026 stood at $2.2 million, down from $5.6 million in the prior quarter.
• Over the last five years, Shares Issued for APGE reached as high as $5.7 million in Q2 2025 and fell as low as $99955.0 in Q1 2024.
• Historically, Shares Issued has averaged $2.8 million across 5 years, with a median of $2.5 million in 2023.
• Across the five-year window, Shares Issued declined 21.97% in 2024 and surged 1043.54% in 2025, its largest moves.
• Year by year, Shares Issued stood at $2.8 million in 2022, then slipped by 9.34% to $2.5 million in 2023, then jumped by 105.72% to $5.2 million in 2024, then grew by 8.83% to $5.6 million in 2025, then plunged by 61.4% to $2.2 million in 2026.
• Per Business Quant data, the three most recent Shares Issued figures were $2.2 million in Q1 2026, $5.6 million in Q4 2025, and $5.7 million in Q3 2025.